Fig. 3
From: hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
hUC-MSC inhibition of B cells subtype in 14-week-old MRL/lpr mice. A The peripheral blood flow cytometry (FCM) gating strategy in MRL/lpr mice. B Proportion of total B cells (a), plasma cells (PC) (b), and plasmablasts cell (PB) (c) in lymphocytes. C The proportion of IgG1− PB (a), IgG1+ PB (b), IgG1− PC (c), and IgG1+ PC (d) in lymphocytes. D The proportion of total IgG1+ MB cells (a), double-negative (DN) MB cells (b), single-positive (SP) MB cells (c), and double-positive (DP) MB cells (d) in total B cells. *P < 0.05; **P < 0.01. (Ctrl: control, LD: low dose, MD: middle dose, HD: high dose). The number of mice is n = 5